Published in
Esmo Open, Esmo Open, 4(8), p. 101588, 2023
DOI: 10.1016/j.esmoop.2023.101588
Links
Tools
Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
Journal article published in 2023 by
M. Kim,
J. L. Lee,
S. J. Shin 
,
W. K. Bae,
H. J. Lee,
J. H. Byun,
Y. J. Choi,
J. Youk,
C. Y. Ock,
S. Kim,
H. Song,
K. H. Park,
B. Keam
,
W. K. Bae,
H. J. Lee,
J. H. Byun,
Y. J. Choi,
J. Youk,
C. Y. Ock,
S. Kim,
H. Song,
K. H. Park,
B. Keam
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Data provided by 